Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qixue Runchang Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by the Beijing University of Chinese Medicine Fangshan District Hospital. It is specifically formulated to treat senile functional constipation, particularly in patients presenting with the "qi and blood deficiency" syndrome according to TCM diagnostic criteria. The formula is designed to improve bowel movement frequency and stool consistency by addressing underlying systemic deficiencies and "moistening the intestines." Clinical evaluation, including the ChiCTR2300067436 trial, compares its efficacy to lactulose and investigates its impact on gut microbiota composition, Wexner constipation scores, and Patient Assessment of Constipation Quality of Life (PAC-QOL) in elderly populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qixue Runchang Formula.